|
|
Article: A new weapon against hypertension: recently approved medication lowers blood pressure, reducing risks of heart failure, stroke, heart attack, aneurysm, and kidney failure.(DRUG WATCH)
- Article from:
- Heart Advisor
- Article date:
- June 1, 2007
CopyrightCOPYRIGHT 2007 Belvoir Media Group, LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
It's been more than a decade since doctors received a new drug to help them battle hypertension (high blood pressure) in patients. During that time, the hypertension epidemic has grown to affect an estimated 25 percent of Americans--and it still remains uncontrolled in nearly 70 percent of those who have it.
That's why the recent approval of a new hypertension drug--aliskiren (Tekturna)--by the U.S. Food and Drug Administration (FDA) is of interest.
"We still see patients who need additional drugs, because the conventional drugs for hypertension are either not controlling their blood pressure adequately or they are not well-tolerated," explains Gary ...
Related newspaper, magazine, and journal articles:
|
|
Article: New Drug Application (NDA) for Rasilez(R) (Aliskiren), an ...
PR Newswire;
April 20, 2006 ;
700+ words
... ... Rasilez produced significant blood pressure reductions sustained over ... combination with other high blood pressure medicines EAST HANOVER ... application for Rasilez (aliskiren) as a treatment for high blood pressure. As a renin inhibitor ...
|
|